IMMUNOLIGHT Trademark

Trademark Overview

On Friday, August 26, 2022, a trademark application was filed for IMMUNOLIGHT with the United States Patent and Trademark Office. The USPTO has given the IMMUNOLIGHT trademark a serial number of 97976327. The federal status of this trademark filing is REGISTERED as of Tuesday, October 17, 2023. This trademark is owned by IMMUNOLIGHT, LLC. The IMMUNOLIGHT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
immunolight

General Information

Serial Number97976327
Word MarkIMMUNOLIGHT
Filing DateFriday, August 26, 2022
Status700 - REGISTERED
Status DateTuesday, October 17, 2023
Registration Number7197942
Registration DateTuesday, October 17, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 14, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 14, 2022
Primary Code005
First Use Anywhere DateTuesday, May 31, 2022
First Use In Commerce DateTuesday, May 31, 2022

Trademark Owner History

Party NameIMMUNOLIGHT, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDetroit, MI 48226
Party NameIMMUNOLIGHT, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDetroit, MI 48226
Party NameIMMUNOLIGHT, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDetroit, MI 48226

Trademark Events

Event DateEvent Description
Tuesday, October 17, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 17, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, September 13, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 12, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, August 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 24, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 3, 2023USE AMENDMENT FILED
Thursday, August 3, 2023SOU EXTENSION 1 GRANTED
Thursday, August 3, 2023SOU EXTENSION 1 FILED
Thursday, August 24, 2023DIVISIONAL PROCESSING COMPLETE
Thursday, August 3, 2023DIVISIONAL REQUEST RECEIVED
Thursday, August 24, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 3, 2023TEAS REQUEST TO DIVIDE RECEIVED
Thursday, August 3, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 3, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, April 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 14, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 25, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 11, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 27, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 27, 2022NON-FINAL ACTION E-MAILED
Tuesday, December 27, 2022NON-FINAL ACTION WRITTEN
Tuesday, December 27, 2022ASSIGNED TO EXAMINER
Wednesday, November 2, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 2, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 14, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 30, 2022NEW APPLICATION ENTERED

Related Keywords

immunolight cancer treatment preparations pharmaceutical